These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 8966508

  • 1. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H, de Moerloose P, Campana A.
    Schweiz Med Wochenschr; 1996 Oct 12; 126(41):1756-63. PubMed ID: 8966508
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Venous thromboembolism in relation to oral contraceptive use.
    Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S.
    Obstet Gynecol; 1987 Jan 12; 69(1):91-5. PubMed ID: 3796927
    [Abstract] [Full Text] [Related]

  • 8. [Effect of hormonal changes in women on hemostasis].
    Malý J, Dulícek P.
    Vnitr Lek; 2002 Dec 12; 48(12):1169-73. PubMed ID: 12642936
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.
    Thromb Haemost; 1997 Dec 12; 78(6):1480-3. PubMed ID: 9423798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 12; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 14. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O, Spinar J, Musil V, Pozdísek Z.
    Vnitr Lek; 2010 May 12; 56(5):370-5. PubMed ID: 20578585
    [Abstract] [Full Text] [Related]

  • 15. [Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease].
    Thery C, Prat A, Asseman P, Bauchart JJ, Michon P, Lesenne M, Jude B.
    Therapie; 1997 May 12; 52(3):165-8. PubMed ID: 9366099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP.
    Thromb Haemost; 1998 Sep 12; 80(3):382-7. PubMed ID: 9759614
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hormone therapy and thromboembolic disease.
    Battaglioli T, Martinelli I.
    Curr Opin Hematol; 2007 Sep 12; 14(5):488-93. PubMed ID: 17934355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.